Connect with us

Top Stories

Propeller Health Raises Strategic Investment from McKesson Ventures

Published

on

Propeller Health Raises Strategic Investment from McKesson Ventures

Propeller Health, a leading digital therapeutics company, announced a strategic investment of an undisclosed amount from McKesson Ventures, adding to the $20M funding round announced last week.

Proceeds from the investment will provide further support for Propeller’s development of additional connected medicines for the treatment of chronic respiratory disease, such as injectables for severe asthma, and expansion into new therapeutic areas, which may include immunology, diabetes, migraine and other diseases with high unmet medical need.

“We’ve accumulated the expertise, infrastructure and distribution network to put connected medicines in the hands of people around the world,” said David Van Sickle, co-founder and CEO of Propeller Health. “This strategic investment accelerates those efforts and provides opportunities to explore potential partnership models that can increase access to new digital medicines and positively impact more lives.”

The Propeller platform enables leading medical technology and pharmaceutical companies to conceptualize, develop and commercialize digital medicines. Propeller also offers distribution at scale through its network of leading payers, pharmacies and PBMs such as Express Scripts.

“Propeller’s strong base of clinical evidence demonstrates meaningful benefits to patients and all key stakeholders involved in delivering patient care. We are excited for their continued success as part of the ‘digital supply chain,’ an emerging category that will be integral to the future of medicine,” said Carrie Hurwitz Williams, Principal of McKesson Ventures.

“McKesson Ventures is uniquely positioned to help accelerate growth in the digital supply chain as our healthcare system becomes increasingly connected via secure data exchange and the use of digital therapies continues to rise.”

Propeller recently announced a strategic partnership with Aptar Pharma to collaborate on the development of digital medicines for multiple therapeutic areas and diseases.

In addition to supporting better self-management and clinical care and treatment, Propeller is working with industry experts and regulators to advance clinical research, real-world evidence and the design and validation of novel endpoints.

Propeller’s platform is backed by 8 FDA 510(k) clearances and CE marking, and the company continues to expand its global operations, now spanning 16 countries. Propeller’s respiratory products have demonstrated significant increases in medication adherence  and health outcomes while delivering reductions in healthcare utilization, such as emergency room visits and hospitalizations.

Top Stories

U.S. oil industry lobby weighs support of carbon pricing – source

Published

on

U.S. oil industry lobby weighs support of carbon pricing - source 1

By Valerie Volcovici

WASHINGTON (Reuters) – The American Petroleum Institute (API) is weighing endorsing a price on carbon emissions, a major shift after long resisting mandatory government climate policies, a source familiar with the decision making said.

The API, the main U.S. oil industry lobby group that includes most of the world’s biggest oil companies, is considering carbon pricing “among other policy solutions to reduce emissions and reach the ambitions of the Paris Agreement,” the source said, confirming a report about the policy shift by the Wall Street Journal.

The group is confronting its previous resistance to regulatory action on climate change amid a shift in industry strategy on the issue and the new U.S. presidency.

European member Total quit the group because of disagreements over API’s climate policies and support for easing drilling regulations and the Biden administration is pursuing a policy agenda that would shift the United States from fossil fuels.

A draft statement of the policy shift reviewed by the Wall Street Journal said the group does not endorse a specific carbon pricing tool such as a tax on carbon emissions or emissions trading scheme. The source said, however, that the group’s State of American Energy report released in January was supportive of a market-based carbon pricing policy.

The API did not comment on whether or when the group would formally endorse a price on carbon but said it has been working for nearly a year on an industry-wide response to climate change.

“Our efforts are focused on supporting a new U.S. contribution to the global Paris agreement,” said API spokeswoman Megan Bloomgren.

Within API, there has been a widening rift between Europe’s top energy companies https://www.reuters.com/article/us-total-api/frances-total-quits-top-u-s-oil-lobby-in-climate-split-idUSKBN29K1LM, which over the past year accelerated plans to cut emissions and build large renewable energy businesses, and their U.S. rivals Exxon Mobil Corp and Chevron Corp that have resisted growing investor pressure to diversify.

Other major industry groups like the U.S Chamber of Commerce and the Business Roundtable https://www.reuters.com/article/usa-business-carbonpricing/u-s-ceo-group-says-it-supports-carbon-pricing-to-fight-climate-change-idUSKBN2672W4, which includes Chevron, over the last year have endorsed market-based carbon pricing.

Chevron said it has engaged those groups and API “to support well-designed carbon pricing.”

“We support economy-wide carbon pricing as the primary policy tool to address climate change, applied across the broadest possible area to maximize environmental and economic efficiency and effectiveness,” Chevron spokesman Sean Comey said in an e-mailed statement.

BP and Shell declined to comment.

(Reporting by Valerie Volcovici; Editing by Chizu Nomiyama and Christian Schmollinger)

Continue Reading

Top Stories

Australian economy storms ahead as COVID recovery turns ‘V-shaped’

Published

on

Australian economy storms ahead as COVID recovery turns 'V-shaped' 2

By Swati Pandey

SYDNEY (Reuters) – Australia’s economy expanded at a much faster-than-expected pace in the final quarter of last year and all signs are that 2021 has started on a firm footing too helped by massive monetary and fiscal stimulus.

The economy accelerated 3.1% in the three months to December, data from the Australian Bureau of Statistics (ABS) showed on Wednesday, higher than forecasts for a 2.5% rise and follows an upwardly revised 3.4% gain in the third quarter.

Despite the best ever back-to-back quarters of growth, annual output still shrank 1.1%, underscoring the havoc wreaked by the coronavirus pandemic and suggesting policy support will still be needed for the A$2 trillion ($1.57 trillion) economy.

The Australian dollar rose about 10 pips to a day’s high of $0.7836 after the data while bond futures nudged lower with the three-year contract implying an yield of around 0.3% compared with the official cash rate of 0.1%.

“The ‘V-shaped’ nature of the recovery is everywhere to see – economic growth, the job market, retail spending and the housing market,” said Craig James, Sydney-based chief economist at CommSec.

James expects the economy to rebound 4.2% in 2021.

Data on credit and debit card spending by major banks as well as official figures on retail sales, employment and building activity point to a strong start for this year.

Marcel Thieliant, economist at Capital Economics, expects GDP growth of 4.5% in 2021, “which implies that allowing for the slump in net migration due to the closure of the border, the economy will suffer no permanent drop in output as a result of the pandemic.”

SUPPORT STILL NEEDED

Australia’s economy has performed better than its rich-world peers thanks to very low community transmission of COVID-19 together with massive and timely fiscal and monetary stimulus.

Its economic output declined 2.5% in 2020, far smaller than a 10% drop in United Kingdom, falls of 9% in Italy, 5% in Canada and more than 3% in the United States.

“Our economic recovery plan is working, and today’s national accounts is a testament to that fact,” Treasurer Josh Frydenberg said in a news conference. “The job is not done,” he added.

“There are challenges ahead. But you wouldn’t want to be in any other country but Australia as we begin 2021.”

To help blunt the economic shock from the pandemic-driven shutdowns, the Reserve Bank of Australia (RBA) slashed interest rates three times last year to a record low 0.1% and launched an unprecedented quantitative easing programme. The government announced a wage subsidy scheme to keep people in jobs while banks deferred payments on home loans and cut borrowing rates to help boost credit growth.

On Tuesday, the RBA re-committed to keep three-year yields at 0.1% until its employment and inflation objectives are met, which policymakers don’t expect until 2024 at the earliest.

Indeed, Wednesday’s data showed there was barely any domestic-driven inflation in the economy with the biggest price rises coming from commodity exports.

The RBA has repeatedly said the unemployment rate must fall to around 4% from above 6% now to help drive wages growth above 3% and for inflation to pop back into its 2-3% target band.

“Stimulus and support measures are still very much required,” CommSec’s James said. “Spare capacity will remain in the job market for a few more years, keeping the cash rate anchored at 0.1%.”

($1 = 1.2780 Australian dollars)

(Reporting by Swati Pandey; Editing by Sam Holmes)

Continue Reading

Top Stories

Oil rises on demand hopes after days of sell-off

Published

on

Oil rises on demand hopes after days of sell-off 3

By Shu Zhang

SINGAPORE (Reuters) – Oil prices rose on Wednesday, boosted by demand hopes on progress made in U.S. vaccine rollouts, while uncertainty over how much supply OPEC+ will restore to the market at its Thursday meeting and a big build in U.S. crude stocks capped gains.

U.S. West Texas Intermediate (WTI) crude futures rose 18 cents, or 0.3%, to $59.93 a barrel by 0356 GMT, recovering from three days of losses.

Brent crude futures rose 29 cents, or 0.46%, to $62.99 a barrel, up from four days of losses.

Both futures had dipped in Asia’s early morning trading.

Demand recovery hopes thanks to the rollouts of vaccine kept oil prices supported, analysts said.

The U.S. will have enough COVID-19 vaccine for every American adult by the end of May, President Joe Biden said on Tuesday after Merck & Co agreed to make rival Johnson & Johnson’s inoculation.

Meanwhile, the market’s attention is on a forthcoming Thursday meeting by the Organization of the Petroleum Exporting Countries (OPEC) and allies, together called OPEC+, at a time when they are generally positive on the oil market outlook compared with a year ago when they slashed supply to boost prices.

The market widely expects them to ease production cuts, which were the deepest ever, by about 1.5 million barrels per day (bpd), with OPEC’s leader, Saudi Arabia, ending its voluntary production cut of 1 million bpd.

However, a JTC document, seen by Reuters, called “for cautious optimism,” citing “the underlying uncertainties in the physical markets and macro sentiment, including risks from COVID-19 mutations that are still on the rise”.

Reinforcing concerns of potential oversupply, the American Petroleum Institute industry group reported U.S. crude stocks rose by 7.4 million barrels in the week to Feb. 26, in stark contrast to analysts’ estimates for a draw of 928,000 barrels. [API/S]

“The recent selloff may help reinforce Saudi’s cautious stance and delay any production increase,” said Stephen Innes, global market strategist at Axi.

“It’s probably something that could sway the OPEC+ increase more back toward the 500,000 bpd as opposed to the 1.5 million bpd,” he said.

(Reporting by Shu Zhang and Sonali Paul; Editing by Kenneth Maxwell and Gerry Doyle)

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call For Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Articles

X-by-Wire Market Report | Size, Growth, Demand, Scope, Opportunities and Forecast 2017-2027 4 X-by-Wire Market Report | Size, Growth, Demand, Scope, Opportunities and Forecast 2017-2027 5
Research Reports5 mins ago

X-by-Wire Market Report | Size, Growth, Demand, Scope, Opportunities and Forecast 2017-2027

Future Market Insights (FMI) has recently published a new market research report on x-by-wire. The report provides incisive insights on the...

Countertop Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2017-2026 6 Countertop Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2017-2026 7
Research Reports6 mins ago

Countertop Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2017-2026

Future Market Insights presents yet another comprehensive and an insightful report titled ‘Countertop Market: Global Industry Analysis 2012 – 2016...

Carbon Fiber Reinforced Plastic Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players -Mitsubishi Rayon Co. Ltd, Cytec Industries Inc., SGL Group Inc. 8 Carbon Fiber Reinforced Plastic Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players -Mitsubishi Rayon Co. Ltd, Cytec Industries Inc., SGL Group Inc. 9
Research Reports7 mins ago

Carbon Fiber Reinforced Plastic Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players -Mitsubishi Rayon Co. Ltd, Cytec Industries Inc., SGL Group Inc.

The market report envelopes an all-in information of the global Carbon Fiber Reinforced Plastic market and the nature of the market growth over...

Variable Air Volume System Market Market financial guide for 2025 by leading players Honeywell International Inc, Schneider Electric, KMC Controls Inc 10 Variable Air Volume System Market Market financial guide for 2025 by leading players Honeywell International Inc, Schneider Electric, KMC Controls Inc 11
Research Reports7 mins ago

Variable Air Volume System Market Market financial guide for 2025 by leading players Honeywell International Inc, Schneider Electric, KMC Controls Inc

The market report envelopes an all-in information of the global Variable Air Volume System market and the nature of the market growth over...

Functional Coil Coatings Market Size, Share, Trends, Application Analysis and Growth by Forecast to 2017-2027 12 Functional Coil Coatings Market Size, Share, Trends, Application Analysis and Growth by Forecast to 2017-2027 13
Research Reports16 mins ago

Functional Coil Coatings Market Size, Share, Trends, Application Analysis and Growth by Forecast to 2017-2027

The comprehensive research report assists the reader in devising and implementing key strategies with a view to gain stability in...

Newsletters with Secrets & Analysis. Subscribe Now